biostudies-literatureUnknown11(2)Wei J<h4>Background</h4>Transurethral split of the prostate (TUSP) is effective in treating benign prostatic hyperplasia (BPH). However, there is still a lack of research focusing on the optimal target population for TUSP. This study aimed to compare the efficacy of TUSP in patients with different prostate volumes or ages.<h4>Methods</h4>The study was a multicenter retrospective study. The outcomes of TUSP in BPH patients with different prostate volumes or different ages were compared. A total of 439 patients were included in the study. Patients were divided into two groups according to prostate volume, with a cut-off value of 50 mL. Similarly, the cut-off value for the age groups was 70 years. Baseline patient characteristics and perioperative outcomes were recorded. Follow-up was performed atTranslational andrology and urology213-227https://www.ebi.ac.uk/biostudies/studies/S-EPMC8899149biostudies-literatureA multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia.PMC8899149Shao HKe MLong HWang BLv WCai MWan LSun CLiu SWang HZhang SShi ZWen JLiang HWang SZhou GChen YWei JQian JFan YHe JYang BChen BYang ZDu CHuangfu QfalseA multicenter retrospective study of transurethral prostate split for benign prostate hyperplasia.<h4>Background</h4>Transurethral split of the prostate (TUSP) is effective in treating benign prostatic hyperplasia (BPH). However, there is still a lack of research focusing on the optimal target population for TUSP. This study aimed to compare the efficacy of TUSP in patients with different prostate volumes or ages.<h4>Methods</h4>The study was a multicenter retrospective study. The outcomes of TUSP in BPH patients with different prostate volumes or different ages were compared. A total of 439 patients were included in the study. Patients were divided into two groups according to prostate volume, with a cut-off value of 50 mL. Similarly, the cut-off value for the age groups was 70 years. Baseline patient characteristics and perioperative outcomes were recorded. Follow-up was performed at2022-01-01T00:00:00Z2022 Feb2025-04-04T19:40:35.486Z2025-04-04T19:40:35.486ZS-EPMC88991493528066510.21037/tau-21-1138